Red cell mass measurement in patients with clinically suspected diagnosis of polycythemia vera or essential thrombocythemia

47Citations
Citations of this article
62Readers
Mendeley users who have this article in their library.

Abstract

The cut off for hemoglobin or hematocrit that indicates the need for an isotopic red cell mass study was investigated in 179 patients with a presumptive diagnosis of polycythemia vera or essential thrombocythemia. Hematocrit showed better diagnostic accuracy than hemoglobin. Hemoglobin over 18.5 g/dL in males or over 16.5 g/dL in females showed a high specificity indicating that red cell mass study could be avoided in such cases, but it showed low sensitivity leading to 46% false negatives. The best value of hematocrit to indicate a red cell mass study was 0.50 L/L in males (specificity 75%, sensitivity 87.5%) and 0.48 L/L in females (specificity 73%, sensitivity 94%). Lowering the hematocrit threshold to 0.48 L/L in males increased sensitivity up to 95%. A red cell mass study should be performed in patients with suspected diagnosis of essential thrombocythemia or polycythemia vera and with hematocrit between 0.48 L/L and 0.52 L/L. ©2012 Ferrata Storti Foundation.

Cite

CITATION STYLE

APA

Alvarez-Larrán, A., Ancochea, A., Angona, A., Pedro, C., García-Pallarols, F., Martínez-Avilés, L., … Besses, C. (2012). Red cell mass measurement in patients with clinically suspected diagnosis of polycythemia vera or essential thrombocythemia. Haematologica, 97(11), 1704–1707. https://doi.org/10.3324/haematol.2012.067348

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free